- Home
- FluxMPS™ RPMI 1640 Medium with 25mM HEPES w/o L-Glutamine, Sodium Bicarbonate, Phenol Red: 1X Liquid
FluxMPS™ RPMI 1640 + 25mM HEPES
FluxMPS™ DCP-RPMIH-QBR1X is a Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) RPMI 1640 + 25 mM HEPES formulation engineered for hematopoietic cells, lymphocytes, and related immune-cell models on organ-on-a-chip (OoC) and microphysiological system (MPS) platforms. The 0.04 µm final cut-off is five times finer than the 0.22 µm membranes used in conventional sterile filtration of RPMI media. HEPES (25 mM, pKa 7.3 at 37°C) provides CO₂-independent pH buffering, and the bicarbonate-free, phenol-red-free formulation supports open-bench handling and fluorescence-based immune assays. Formulation: [+] HEPES (25 mM), [+] Calcium, [+] Magnesium, [+] Glucose (2.0 g/L), [+] Sodium Pyruvate (110 mg/L) | [-] L-Glutamine, [-] Sodium Bicarbonate, [-] Phenol Red.
- Glucose source retained: 2000 mg/L (2.0 g/L) — full carbon source despite HEPES-only buffering
- 25 mM HEPES (pKa 7.3 at 37°C) provides robust, CO₂-independent pH buffering for open-bench and imaging workflows
- Glutathione (reduced), 1.000 mg/L — antioxidant support for redox-sensitive immune cell types
- Quadruple-stage filtration train (0.1 µm ×2 + 0.04 µm ×2) reaching a 0.04 µm final cut-off
- Endotoxin release specification: < 0.05 EU/mL by LAL assay (USP <85>)
- Bicarbonate-free and phenol-red-free — reduces autofluorescence background for PE-channel flow cytometry and confocal imaging
- Manufactured under an ISO 13485:2016 quality management system; final QC at Diagnocine, Totowa, NJ
- Custom pH, nutrient, and HEPES concentration modifications available on request
- Media familyRPMI 1640 + 25mM HEPES
- Glucose2000 mg/L (2.0 g/L)
- HEPES25 mM (pKa 7.3 at 37°C)
- Formulation[+] HEPES (25 mM), [+] Calcium, [+] Magnesium, [+] Glucose (2.0 g/L), [+] Sodium Pyruvate (110 mg/L) | [-] L-Glutamine, [-] Sodium Bicarbonate, [-] Phenol Red
- pH (USP <791>)7.4
- Osmolality (USP <785>)230–270 mOsm/kg H₂O
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2 (Quadruple-stage)
- Storage2–8°C, protect from light
- Shelf Life12 months from date of manufacture, unopened
Engineered where standard media fails
Conventional 0.22 µm–filtered RPMI passes subvisible particulates and mycoplasma-sized bioburden that standard filtration cannot retain. FluxMPS™ DCP-RPMIH-QBR1X is built around a validated quadruple-stage filtration train and a formulation tailored for immune-cell and hematopoietic culture.
Microchannel-safe purity
0.04 µm final filtration with USP <788> Method 1 (light obscuration) particulate compliance testing supports suspension immune-cell OoC and microfluidic channel applications.
Defined metabolic profile
2.0 g/L glucose and 110 mg/L sodium pyruvate are held to a fixed, released specification, supporting reproducible metabolic flux and glycolysis studies in lymphocyte and cancer cell lines.
Ultrapure-grade water
Type 1 water (18.2 MΩ·cm) supports low trace-metal and low-TOC formulation control during manufacture.
Low background for imaging
0.04 µm filtration reduces the particulate baseline for confocal and biosensor imaging. Note: riboflavin (0.200 mg/L) contributes intrinsic media autofluorescence near 525 nm, independent of filtration — account for this in fluorescence assay design.
Rich, stable nutrient profile
19 amino acids, 11 vitamins, and glutathione (reduced antioxidant) formulated to a fixed release specification and produced under micro-batch, per-lot QC.
Customization on demand
pH, nutrient concentrations, HEPES, and component modifications available. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration passes — two dedicated prefilter + final-filter pairs — reaching a final 0.04 µm polish.
-
1
0.1 µm Prefiltration I
Removes large aggregates and cell debris; protects the first 0.04 µm cartridge.
-
2
0.04 µm Final filtration I
First 0.04 µm pass; retains sub-micron particulates and microaggregates that a 0.22 µm filter would pass.
-
3
0.1 µm Prefiltration II
Second dedicated prefilter, protecting the second 0.04 µm cartridge.
-
4
0.04 µm Final filtration II — Polish
Ultimate polishing filter ahead of aseptic fill & finish in validated ISO Class 5 (Class 100) conditions.
Performance vs. conventional media
FluxMPS™ DCP-RPMIH-QBR1X is processed through a quadruple-stage filtration train reaching a 0.04 µm final cut-off — five times finer than the 0.22 µm membranes used in conventional sterile filtration of RPMI 1640 media.
© Diagnocine® — DCP-RPMIH-QBR1X
Immune cell OoC and hematopoietic applications
FluxMPS™ DCP-RPMIH-QBR1X — RPMI 1640 + 25mM HEPES — delivers 0.04 µm filtered, Microfluidics Suitable media for hematopoietic cells and related OoC applications.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) ultra nano-filtered MPS Grade variant of this formulation is available on request for automated perfusion systems.
- Extended particulate exclusion: 0.01 µm filtration targets nanoparticulate aggregates beyond the 0.04 µm cut-off
- Valve & sensor protection: reduces micro-fouling risk in automated perfusion systems
- Extended perfusion stability: supports consistent nutrient delivery over long-duration culture
Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.
T Cell & Lymphocyte Culture
RPMI 1640 is the standard base for primary T cells, B cells, NK cells, and monocytes. FluxMPS™ 0.04 µm filtration lowers the particulate baseline relevant to immune assays.
Leukemia & Lymphoma Lines
RPMI supports Jurkat, Raji, K562, HL-60, and other hematopoietic cancer lines where DMEM formulation would alter proliferation and signaling.
Immune Cell OoC
0.04 µm filtered RPMI for tumor-immune interaction chips, vascular-immune OoC, and lymph-node-on-chip platforms.
CAR-T & TIL Expansion
Low endotoxin release specification (< 0.05 EU/mL) supports CAR-T manufacturing and TIL expansion protocols where endotoxin can activate TLR4 signaling in T cells.
Immune Cell Metabolic Flux
Bicarbonate-free, phenol-red-free base compatible with Agilent Seahorse XF T cell metabolic assays, glycolysis stress tests, and ¹³C isotope tracing of lymphocyte activation states.
Flow Cytometry & Confocal
Phenol-red-free formulation reduces background absorbance for PE-channel flow cytometry and confocal imaging of immune cells; see the imaging note in Why FluxMPS™ regarding riboflavin autofluorescence.
Analytical release specifications
Every lot released against the full specification matrix. Available sizes: 500 mL, 1000 mL. CoA: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] HEPES (25 mM), [+] Calcium, [+] Magnesium, [+] Glucose (2.0 g/L), [+] Sodium Pyruvate (110 mg/L) | [-] L-Glutamine, [-] Sodium Bicarbonate, [-] Phenol Red |
| Appearance | Pale yellow, clear solution (phenol red-free) |
| Glucose | 2000 mg/L (2.0 g/L) |
| HEPES | 25 mM (pKa 7.3 at 37°C) |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | 230–270 mOsm/kg H₂O |
| Total ingredients | 39 |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | NMT 25/mL |
| Particulate ≥25 µm USP <788> Method 1 | NMT 3/mL |
| Water purity | Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, protect from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO₂ requirement | CO₂-independent — 25 mM HEPES buffering maintains pH stability without a CO₂ incubator |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
RPMI 1640 + 25mM HEPES: 39 ingredients verified per lot with CAS numbers for full raw-material traceability. Contains glutathione (reduced antioxidant) and a balanced profile of amino acids and vitamins optimized for lymphocyte and hematopoietic cell culture.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium nitrate tetrahydrate | 13477-34-4 | 100.000 |
| Magnesium sulfate anhydrous | 7487-88-9 | 48.840 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium chloride | 7647-14-5 | 6000.000 |
| Sodium phosphate dibasic anhydrous | 7558-79-4 | 800.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| Glycine | 56-40-6 | 10.000 |
| L-Arginine hydrochloride | 1119-34-2 | 241.000 |
| L-Asparagine | 70-47-3 | 50.000 |
| L-Aspartic acid | 56-84-8 | 20.000 |
| L-Cystine dihydrochloride | 30925-07-6 | 65.200 |
| L-Glutamic acid | 56-86-0 | 20.000 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 20.960 |
| L-Hydroxyproline | 51-35-4 | 20.000 |
| L-Isoleucine | 73-32-5 | 50.000 |
| L-Leucine | 61-90-5 | 50.000 |
| L-Lysine hydrochloride | 657-27-2 | 40.000 |
| L-Methionine | 63-68-3 | 15.000 |
| L-Phenylalanine | 63-91-2 | 15.000 |
| L-Proline | 147-85-3 | 20.000 |
| L-Serine | 56-45-1 | 30.000 |
| L-Threonine | 72-19-5 | 20.000 |
| L-Tryptophan | 73-22-3 | 5.000 |
| L-Tyrosine Disodium Salt | 69847-45-6 | 28.830 |
| L-Valine | 72-18-4 | 20.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 3.000 |
| D-Biotin | 58-85-5 | 0.200 |
| D-Ca-Pantothenate | 137-08-6 | 0.250 |
| Folic acid | 59-30-3 | 1.000 |
| Niacinamide | 98-92-0 | 1.00 |
| Pyridoxine hydrochloride | 58-56-0 | 1.00 |
| Riboflavin | 83-88-5 | 0.200 |
| Thiamine hydrochloride | 67-03-8 | 1.000 |
| Vitamin B12 | 68-19-9 | 0.005 |
| i-Inositol | 87-89-8 | 35.000 |
| p-Amino benzoic acid (PABA) | 150-13-0 | 1.000 |
| OTHERS | ||
| D-Glucose | 50-99-7 | 2000.000 |
| Glutathione reduced | 70-18-8 | 1.000 |
| HEPES | 7365-45-9 | 5958.00 |
| Sodium pyruvate | 113-24-6 | 110.000 |
Manufacturing & compliance
Every FluxMPS™ product is manufactured and released under a multi-layer quality system.
ISO 13485:2016 Quality Management
Manufactured under an ISO 13485:2016 quality management system. Final QC at Diagnocine, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm — supports low trace-metal, low-TOC formulation control.
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.
Micro-Batch Precision
Small-batch, per-lot tested — Certificate of Analysis available for every batch.
Endotoxin — USP <85> BET
LAL assay; release specification < 0.05 EU/mL per batch.
Particulate — USP <788> Method 1
Light obscuration; NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm).
Osmolality — USP <785>
Target: 230–270 mOsm/kg H₂O.
Documentation & CoA
Full CoA with raw-material traceability available on request.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-RPMIH-QBR1X compares
FluxMPS™ DCP-RPMIH-QBR1X vs. conventional 0.22 µm–filtered RPMI formulations.
| Parameter | DCP-RPMIH-QBR1X (FluxMPS™) | Conventional RPMI 1640 + HEPES (0.22 µm filtered) |
Standard DMEM/RPMI (0.22 µm filtered) |
|---|---|---|---|
| Grade | Microfluidics Suitable | Not specified | Not specified |
| RPMI 1640 + HEPES-only, CO₂-free — no glutamine, no phenol red | check_circle Yes | cancel No | cancel No |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration passes | 4 | 1 | 1 |
| Mycoplasma-retentive filtration | check_circle Yes (0.1 µm stages) | cancel No | cancel No |
| Endotoxin (release specification) | < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP <788> particulate tested (Method 1) | check_circle Yes | cancel No | cancel No |
| Water quality | Type 1, 18.2 MΩ·cm | Purified water | Purified water |
| Manufacturing QMS | ISO 13485:2016 | ISO 9001 or none | ISO 9001 or none |
| Microfluidic channel compatible | check_circle Microfluidics Suitable | cancel Risk of clogging | cancel Risk of clogging |
| Custom formulation | check_circle Yes | cancel No | cancel No |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DCP-RPMIH-QBR1X — RPMI 1640 + 25mM HEPES.
Supporting literature
Key publications supporting RPMI 1640 + 25mM HEPES in immune cell culture and OoC applications.
- Moore GE, et al. Culture of normal human leukocytes. JAMA. 1967;199:519–524. doi:10.1083/jcb.1.3.273
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
- Jang KJ, et al. Human kidney proximal tubule-on-a-chip. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
- Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
- Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446–452. doi:10.1038/nmeth.3832
- Sung JH, et al. Microfabricated mammalian organ systems. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j

